Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Teva to pay $512 million in Provigil settlement – report

“Reuters” said the settlement would be the largest ever paid over allegations of delaying generic drugs.

Teva CEO Erez Vigodman

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has agreed to pay $512 million to settle a class action suit, reports “Reuters.” The class action claims that Cephalon Inc., which Teva bought in 2011, “used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers, ” says “Reuters.”
GLOBES logo-eng (1)

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.